study question: Do cleavage-stage embryos obtained from oocytes matured in vitro after pre-incubation with a phosphodiesterase inhibitor (IBMX) carry more chromosomal abnormalities than those generated from oocytes matured in vivo?
Introduction
In vitro maturation (IVM) of mid-antral oocytes is a promising patientfriendly assisted reproductive technology (ART) that has been proposed for a variety of indications. IVM is most commonly used for patients with polycystic ovaries (PCO) or polycystic ovary syndrome (PCOS) because of the increased risk of ovarian hyperstimulation syndrome (OHSS) in these patients (Fauser and Van Heusden, 1997; Swanton et al., 2010; Guzman et al., 2013) . PCOS patients represent 5-10% of women of reproductive age (Svendsen et al., 2010) . Other non-medical indications include the reduction of the cost of hormonal treatment in couples with male infertility (Fadini et al., 2013) . Finally, IVM has been proposed for patients with a contra-indication for conventional ovarian stimulation or with limited time to obtain oocytes, such as cancer patients facing chemotherapy-induced loss of germ cells (Fadini et al., 2013) . However, IVM is still not used widely due to the high miscarriage rates and the lower clinical pregnancy rates, and the perceived safety issues related to in vitro culture (Cobo et al., 1999; Dal Canto et al., 2006; Jurema and Nogueira, 2006; Fadini et al., 2009; Son and Tan, 2010) .
The exact causes underlying reduced clinical outcomes after IVM are not completely understood. Reduced developmental capacity of IVM oocytes as a consequence of inadequate in vitro oocyte maturation conditions is a recognized cause of inefficiency (reviewed by Gilchrist, 2011) . Novel culture methods containing molecules that delay meiotic resumption have been shown to enhance efficiency in IVM systems, at least in animals . However, it cannot be ruled out a priori that lower implantation rates in IVM cycles are dictated by insufficient endometrial receptivity (De Vos et al., 2011) . Although there is still uncertainty with regard to the optimal clinical protocol of IVM cycles (e.g. with or without hCG triggering), the composition of the IVM culture system is an important focus of ongoing research . Standard IVM culture media result in spontaneous or premature resumption of meiosis, which has urged several research teams to use cAMP modulators that delay germinal vesicle breakdown to enhance oocyte developmental competence (Tsafriri et al., 1996; Jensen et al., 2002; Nogueira et al., 2003 Nogueira et al., , 2006 Luciano et al., 2004; Thomas et al., 2004; Vanhoutte et al., 2009; Zeng et al., 2013) . The non-specific phophodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) has been used for decades in animal models to simulate a more physiological induced oocyte maturation. When incorporated into the oocyte maturation system, IBMX results in a significantly improved blastocyst formation rate with a higher cell numbers, than in controls (Luciano et al., 1999 , Albuz et al., 2010 Zeng et al., 2013) . These authors showed that IBMX needs to be included in the collection medium because the hydrolysis of and fall in intra-oocyte cAMP occurs very quickly when an immature oocyte is artificially removed from the follicle, and can only be prevented by the inclusion of phosphodiesterase inhibitors such as IBMX in the collection medium. Nevertheless, chromosomal analysis of embryos generated using a novel simulated physiological oocyte maturation (SPOM) system including IBMX has not been performed; these safety data are crucial for the introduction of this novel technology in human ART.
In human embryos generated after conventional ART protocols, preimplantation genetic screening (PGS) either by fluorescence in situ hybridization (FISH) or array comparative genomic hybridization (aCGH) has revealed high aneuploidy rates (Baart et al., 2006; Daphnis et al., 2008; Gutiérrez-Mateo et al., 2011; van Echten-Arends et al., 2011) , resulting from meiotic or postzygotic errors. Moreover, all studies analysing the chromosomal constitution of all blastomeres of human embryos have confirmed aneuploidy and mosaicism, as identified by the analysis of single biopsied blastomeres (Bielanska et al., 2002; Vanneste et al., 2009; Johnson et al., 2010; Treff et al., 2010; Mertzanidou, et al., 2013a,b) . However, data pertaining to aneuploidy rates in embryos after IVM are scarce. Ao et al. were the first to perform PGS in IVM embryos from a patient with PCO (Ao et al., 2006) . They identified two normal embryos (out of five) that resulted in a singleton pregnancy after transfer. Another study identified aneuploidy and DNA fragmentation in arrested zygotes and embryos in a series of 262 PCOS patients in whom oocyte IVM after hCG priming was carried out. The authors of this study concluded that the rate of chromosome abnormalities in arrested IVM embryos was not significantly different from that reported in arrested IVF or ICSI embryos (Benkhalifa et al., 2009) . While the latter study analysed arrested zygotes and embryos, Zhang et al. used PGS to investigate the incidence of aneuploidy in hCG-primed IVM embryos according to the time needed for an individual oocyte to achieve complete maturation, although the authors acknowledged that their series was too small to draw firm conclusions (Zhang et al., 2010) . The incidence of oocyte aneuploidy by FISH at 48 h after follicle aspiration was 100% (7/7), whereas it was 75% (3/4) in in vivo matured oocytes and 62% (23/37) in embryos from oocytes that meiotically matured 24 h after follicle aspiration. However, they did not observe any difference in aneuploidy rates when comparing IVM and IVF embryos. To our knowledge, with the exception of a case study where IVM was applied to oocytes of a patient carrying a FMR1 mutation, and whose embryos underwent PGD for fragile X syndrome in conjunction with PGS using aCGH (Nayot et al., 2013) , no systematic study of chromosomal abnormalities in embryos obtained after IVM has been published.
The aim of this study was to assess the incidence of chromosomal abnormalities in all blastomeres of human embryos with good morphology generated using an IVM system containing IBMX in the cumulusoocyte complex (COC) collection medium.
Materials and Methods

Patient population
This study was approved by the local ethical committee and the Federal Commission for Scientific Research on embryos and all participating patients and egg donors gave written informed consent. Patients who were eligible for IVM treatment because of PCOS consented to donate a proportion of the oocytes obtained after transvaginal pick-up for the generation of research embryos and aneuploidy testing. All IVM procedures were performed between July 2012 and December 2012. Patients were selected based on circulating baseline anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) .
Between July 2012 and December 2012, 16 women with PCOS (14 of whom were patients and two were egg donors) who volunteered to donate oocytes for this study were included; their clinical parameters are shown in Tables I and II. The diagnosis of PCOS was based on the Rotterdam criteria (Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop Group, 2004) .
All women received 150 IU/day highly purified human menopausal gonadotrophin (HP-HMG, Menopur; Ferring Pharmaceuticals) for 3 days, starting on Day 3 after spontaneous menstruation or progestin-induced withdrawal bleeding. An ovarian ultrasound scan was performed on Day 6 to rule out the emergence of a dominant follicle. All patients underwent transvaginal ovarian puncture for immature oocyte retrieval on cycle day 7, 42 h after the last HP-HMG stimulation dose. To avoid the collection of oocytes at divergent stages of maturation, no hCG ovulation trigger was administered.
Immature oocyte retrieval, IVM, ICSI and embryo culture COCs were retrieved from 2 to 10 mm follicles with a 17-gauge single-lumen needle (K-OPS-1230-VUB; Cook Medical, Brisbane, Australia), at an aspiration pressure of 70 mmHg, and collected into IVM collection medium containing 50 mM IBMX (Sigma) (from Cook Medical; batches TR0518 and TR0527) supplemented with heparin at 10 IU/ml (Heparin Leo, Leo Pharma, Belgium). Follicular aspirates were diluted in IVM collection medium (3 ml per tube), filtered (Falcon 1060; 70 mm mesh size) and COCs were collected from the culture dish and held in collection media for a maximal time of 1 h. COCs were then washed and further cultured at 378C, 6% CO 2 in air, in groups of 10 COCs per well in 4-well IVF dishes (Nunc; Thermo Fisher Scientific; Denmark), each well containing 500 ml of IVM culture media (Cook Medical) supplemented with 100 mIU/ml recombinant FSH (Puregon, Merck Sharp and Dohme). After 40 h of IVM culture, oocytes were mechanically and enzymatically freed from their cumulus layers using hyaluronidase (Cook Medical) under a stereomicroscope and oocyte maturation was assessed under an inverted microscope.
All mature oocytes were microinjected with sperm from a common donor and embryo development was evaluated until Day 3 after ICSI. Fertilization and embryo development were recorded at standard assessment time points. Only embryos with good morphology (grade EQ1 or EQ2 in Papanikolaou et al., 2005) based on the number of blastomeres (at least 6 for EQ2 and 7 for EQ1), rate of fragmentation (,10 for EQ1 and 20% for EQ2), no evidence of multi-nucleation of the blastomeres, and early compaction were selected for genetic analysis. 
Continued
Chromosome analysis of the single blastomeres
The embryo dissociation, cell collection and storage, sample preamplification were done as per Mertzanidou et al. (2013b) while the aCGH and analysis were done as in Jacobs et al. (2014) . Briefly, after removing the zona pellucida with acidified Tyrodes medium, the embryos were disaggregated in Ca 2+ -and Mg 2+ -free medium. Individual blastomeres were washed and collected into sterile 0.2 ml PCR tubes containing 2 ml of phosphate-buffered saline (Cell Signalling Technologies, Beverly, MA, USA) with 0.1% polyvinylpyrrolidone. For DNA preamplification, the SurePlex DNA Amplification System (BlueGnome, Cambridge, UK) was used according to the manufacturer's instructions. Array-based CGH was carried out using version 3 24Sure TM Cytochip microarrays following the standard protocol (BlueGnome 24sure protocol, http://www.cambridgebluegnome.com/). After scanning of the microarray slides, the images were analysed using the software BlueFuse Multi 3.1 (BlueGnome). All genomic positions in this study refer to the human genome build NCBI37. Only arrays with .80% included clones and a signal-to-background ratio .3 were considered and analysed if standard deviation was ≤0.15 and derivative log-ratio ,0.2. However, cells with an apparent chaotic chromosomal content (see Table III ) were considered despite the aberrant standard deviation caused by the strong variations of the log-2 ratios from the baseline by a large number of chromosomes. We used a threshold of 0.31 for the log2 ratio of gains of chromosomal content, and 20.45 for loss of chromosomal content, and only considered abnormalities spanning at least seven consecutive clones. These values were obtained after validation of the platform using single cells containing a priori known abnormalities; the results are described elsewhere (Jacobs et al., 2014) . We made no distinction in the calls for cells containing chromosome losses or gains that appeared to be nullisomies or amplifications, when compared with monosomies or trisomies.
The GEO accession number for the aCGH data reported in this paper is GSE56799.
Results
Two hundred and thirty-nine COCs were retrieved from 16 donors in 18 cycles, 120 of which matured to metaphase II oocytes (50.2%, 120/239). Of these, 82 (68.3%, 82/120) showed normal fertilization and 25 (30.5%, 25/82) developed into good quality embryos by Day 3 of development. The remaining 57 embryos did not meet the minimal criteria for embryo transfer or cryopreservation used in our centre and led to the exclusion of five patients/cycles (Papanikolaou et al., 2005) . The number of embryos selected for analysis per donor varied between one and six (mean 2.27 embryos; 25 embryos from 11 donors). Of the total number of 25 embryos, seven yielded no results because of failure of the preamplification step due to an experimental error. Due to this, two donors had no embryos analysed since the only embryo they donated was not analysed. In the remaining 18 embryos from nine donors, 167 cells and fragments were collected, as we could not always ascertain the presence of a nucleus. Figure 1 shows the morphology of the 18 embryos at the moment before dissociation. One hundred and thirty-six cells were successfully amplified (81.4%, 136/167), showing that a significant number of samples collected were in fact anucleated fragments. An overview of the aCGH results for all successfully amplified cells is shown in Table III . Table III ). Five arrays were of lower quality that still allowed us to interpret whole chromosomal abnormalities but not segmental abnormalities; these five cells are marked with a star in Table III . Forty-three cells (34.9%, 43/123) had a balanced genetic content; thirteen (11.0%, 13 out of 118 cells with aCGH results of sufficient quality to call smaller segments) showed only one or two segmental abnormalities. Twenty-seven cells showed a single chromosome gain (10.6%, 13/123) or loss (11.4%, 14/123), sometimes in combination with a segmental abnormality, whereas five cells contained two gains or losses. Notably for embryo 1, the cells with a loss for chromosome 15 appeared nullisomic rather than monosomic for this chromosome. Eighteen cells (15.2%, 18/118) showed a segmental aberration, five of which were in cells that also carried a chromosome gain or loss. Finally, 22 cells (17.9%, 22/123) displayed a chaotic genetic content defined as containing three or more copy number changes. Chaotic cells generally contained numerous copy number changes, and the abnormalities appeared to be nullisomies or amplifications, based on the log2 ratios in the aCGH plots (for an example see Fig. 3) .
Three of the 18 embryos (16.7%) had a normal chromosomal complement in all cells analysed (embryos 7, 12, 13), and two additional embryos (embryos 4 and 17) were normal in all cells except one, where a segmental aberration was observed. One embryo (embryo 15) had a monosomy 21 in all cells as the only aneuploidy present, suggesting a meiotic error. Five embryos (27.8%; embryos 4, 6, 16, 17 and 18) had over 50% of their cells with a balanced genetic content and three embryos (16.7%; embryos 2, 3 and 14) had ,50% of their cells with a balanced genetic content. Three embryos (1, 10 and 11) were unbalanced mosaics. Thus, overall 11/18 or 61% of IVM embryos were mosaics. These figures are taking segmental abnormalities into account as causing unbalanced genetic content. Finally, three embryos showed chaotic cells in over 80% of their cells. Although impossible toverify in the current cases, we hypothesize that chaotic cells may have originated through endoreduplication of all chromosomes, followed by formation of a multipolar spindle and unequal mitotic division of the chromosomes over the daughter cells, as described in Mertzanidou et al. (2013b) . In this previous study, we were able to show the chain of events in embryos mosaic for both normal and chaotic cells. However, as in the chaotic embryos (5, 8 and 9) in the current study, several cells yielded no results (Figs 1 and 2) ; therefore a reconstruction is not possible in these embryos.
When interpreting aCGH results, such as the del(1)(p36.33p36.13), del(1)(q42.13q44) in cell 7 of embryo 11, it is important to be mindful that aCGH does not visualize chromosomes as classical G-banding does. It is certainly possible that the abnormality observed in this cell is a ring chromosome, rather than a combination of two deletions (Scriven, 2013) . However, the technology we used does not allow us to discriminate between the two possibilities. 
Chromosomes in embryos matured in vitro
Discussion
In conventional ART programs, the final steps of the process of oocyte maturation in vivo are triggered by the injection of hCG. As such, the oocyte undergoes a series of meiotic and molecular changes that are essential to acquire full developmental potential. This process is highly complex and requires the participation of mural granulosa cells and cumulus cells. On the other hand, it has been known for many decades that mammalian oocytes can also spontaneously mature upon release from the follicular environment from unstimulated ovaries (Pincus and Enzmann, 1935) . However, the signalling pathways by which the latter, spontaneous oocyte maturation process occurs in vitro are not physiological and are markedly different from how the oocyte matures in vivo (Russell and Robker, 2007; Gilchrist, 2011) . Hence, spontaneous in vitro oocyte maturation is characterized by multiple cellular and molecular deficiencies compared with oocytes matured in vivo, which culminates in inferior developmental potential of spontaneous IVM oocytes. The diversity of empirical, rather than evidence-based laboratory procedures and stimulation protocols, used for human IVM is an important impediment to the establishment of an efficient IVM clinical protocol. Because of this, clinical results reported in the literature are highly divergent and have not substantially improved (Gremeau et al., 2012) since the first clinical success of IVM was achieved in 1991 (Cha et al., 1991) in normovulatory patients and in 1994 in patients with PCOS (Trounson et al., 1994) .
Recent insights into the regulation of meiotic arrest and the resumption of meiotic progress have resulted in novel IVM systems that are designed to mimic physiological oocyte maturation (Gilchrist, 2011) . Whereas some researchers have focused on the role of epidermal growth factor (EGF)-like proteins (Park et al., 2004; Zamah et al., 2010; Peluffo et al., 2012; Richani et al., 2014a,b) to reproduce the process of in vivo oocyte maturation in vitro, others have investigated the use of cAMP-modulators during IVM to improve subsequent embryo development (Nogueira et al., 2003 Luciano et al., 2004; Thomas et al., 2004; Shu et al., 2008) . Although the latter approach appears to increase blastocyst yield and pregnancy rates, at least in the mouse and in the bovine system (Albuz et al., 2010) , the potential influence of cAMP-modulators in IVM media on the cytogenetic constitution of embryos has never been evaluated. Since cAMP modulators interfere with meiosis, their application in clinical IVM may raise safety concerns. Moreover, increased miscarriage rates have been observed after IVM compared with conventional ART, at least in a retrospective comparative study encompassing 99 patients with PCOS (Buckett et al., 2008) . Although it is unclear to which extent the endocrine-metabolic syndrome itself may result in an increased risk of miscarriage, and although followup studies of health in children born after IVM have yielded reassuring data (Buckett et al., 2007 (Buckett et al., , 2008 Fadini et al., 2012) , there is a clear need for improved knowledge of cytogenetic safety of IVM.
The current results on chromosomal abnormalities in human embryos obtained from in vitro-matured oocytes are very similar to results obtained previously in embryos produced after conventional hormonal stimulation and ICSI. For instance, in our previous study on Day 3 embryos of excellent morphological quality, 48.6% (34/70) of the blastomeres we analysed had a balanced genetic content, while 21.4% (3/14) of the embryos had a fully normal balanced content (Mertzanidou et al., 2013a) . Furthermore, recently we analysed all cells from Day 4 embryos from conventional IVF and obtained comparable results (100/242 or 41.3% balanced blastomeres) showing that at Day 4, chromosomal content of embryos is still very similar to day 3 (Mertzanidou et al., 2013b) . This compares favourably to the 34.9% (43/123) of genetically balanced blastomeres, and 16.7% (3/18) of fully balanced embryos found after IVM in the current study, taking Figure 3 Example of aCGH results from a chaotic embryo. aCGH plots of the analysed cells from embryo 5. All samples are arrayed against female and male reference DNA, and the aCGH plots displayed here show the combined results of the two tests. The thick green line indicates significant deviations from the average log-2 ratio and is used for CNV calling. A green and a red horizontal guideline indicate a log-2 ratio of 0.3 and 20.3, respectively. A blue and red line following the log-2 ratios of the different probes indicate relative log-2 ratios compared with the male (blue) and female (red) reference DNA. into account that all three studies analysed a limited number of embryos (14, 13 and 18, respectively) (Table IV) . It is especially reassuring that only one embryo showed a meiotic abnormality, since in contrast to maturation within a natural site, the in vitro culture of GV oocytes may expose the cell to possible interferences with the meiotic process. For example, it is known that endocrine disruptors such as bisphenol A cause meiotic errors (Nagaoka et al., 2012) , and in that light, adding agents to the medium that interfere with meiosis such as IBMX, must be done with caution. For comparison, in our previous study on Day 3 embryos (Mertzanidou et al., 2013a) , no embryo was found to carry a meiotic error, whereas our study by on Day 4 embryos (Mertzanidou et al., 2013b) revealed 3 out of 13 embryos with a meiotic error. A little over 15% (15.2%, 18/118) of the cells in the current study carried a segmental abnormality, which is in the same range as our previous study on Day 3 embryos where 29% of the cells carried a segmental aberration.
The range of abnormalities found in IVM embryos which have been deliberately exposed for 1 h to 50 mM IBMX is very comparable to what has been found in other studies in embryos generated by conventional ART. Earlier studies using metaphase CGH for molecular karyotyping of single blastomeres showed 41% (26/63, Voullaire et al., 2000) or 56% (36/64, Wells and Delhanty, 2000) balanced cells. Array-based CGH on single blastomeres from PGS embryos as well as on embryos unsuitable for transfer showed 65% (490/759) abnormal cells (Gutiérrez-Mateo et al., 2011) . Analysing single blastomeres with SNP arrays, Johnson et al. (2010) found that 48% (64/134) of cells were euploid. Using data mainly generated by FISH, it has been estimated that around 73% of the embryos at the cleavage stage are mosaic (van Echten-Arends et al., 2011). We previously determined that 78.6% of Day 3 embryos assessed were mosaic (Mertzanidou et al., 2013a) while this figure was 84.6% in our Day 4 embryos (Mertzanidou et al., 2013b) . The mosaicism rate of 77.8% in the current study is in line with these figures. The presence of segmental aberrations in blastomeres is now well established, although the frequency of their occurrence varies in different reports.
Twenty-eight per cent of the chromosomal events observed by metaphase CGH were segmental aberrations (16 out of 57 events) (Daphnis et al., 2008) . Vanneste et al. (2009 Vanneste et al. ( , 2011 using an array-based approach reported that 31% (5/16) to 70% (16/23) of the embryos carried structural abnormalities. In our hands, structural aberrations were found in 15.2% (18/118) of all cells or 55% (10/18) embryos.
Taken together, the rates and types of chromosomal aberrations in IVM embryos analysed in the current study are similar to data obtained from studies on regular IVF embryos, either dissociated and analysed blastomere by blastomere (Voullaire et al., 2000; Wells and Delhanty, 2000; Daphnis et al., 2008; Vanneste et al., 2009; Johnson et al., 2010; Treff et al., 2010; Mertzanidou et al., 2013a,b) , or with one blastomere analysed in a PGS cycle (Gutiérrez-Mateo et al., 2011) .
Oocyte in vitro maturation is an emerging minimal-stimulation ART that eliminates the risk of OHSS in susceptible patients treated with gonadotrophins. The results obtained in this study provide evidence that the incidence of aneuploidy in IVM embryos is low and support the clinical application of IVM as a safe reproductive technique in a selected patient population. Number of embryos with meiotic abnormalities only 1 (5.6%) 0 1 (7.7%)
Supplementary data
Number of embryos with meiotic abnormalities and segmental abnormalities only 0 0 1 (7.7%)
Number of embryos with meiotic abnormalities and mitotic abnormalities 0 0 1 (7.7%)
Number of mosaic embryos with ≥50% balanced cells (segmental only) 5 (2)* (27.8% (11.1%)) 3 (1)* (21.4% (7.1%)) 4 (0)* (30.8%)
Number of mosaic embryos with ,50% balanced cells (segmental only) 3 (0) Chaotic is defined as embryos with ≥75% cells that carry three or more whole chromosome abnormalities.
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Transferable embryos defined as embryos with .50% balanced cells chosen as arbitrary cut-off. *The figures between brackets represent the number of embryos where only segmental aberrations were found.
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